Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 4;14:1707–1718. doi: 10.2147/OTT.S300623

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Li et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Validation of the identified association of CA12 transcription level with clinicopathological factors using TCGA database. The landscape of CA families and their relationship between diverse diagnostically relevant clinicopathological factors in TCGA Database (A). High CA12 mRNA levels significantly associate with WHO IV grade (B), IDH1 wildtype DNA status (C), tumors with 1p/19q chromosome arm co-deletion (D) and CA12 tumors carrying de-methylated MGMT promoter region (E). CA12 mRNA is significantly upregulated in the most aggressive mesenchymal subtype of GBM (F).